| Literature DB >> 34946854 |
Xiaolei Lin1, Hongzhe Li1, Tianke Yang1, Xin Liu1, Fan Fan1, Xiyue Zhou1, Yi Luo1.
Abstract
To gain insight into the aetiology of posterior subcapsular congenital cataract from the perspective of transcriptional changes, we conducted an mRNA sequencing analysis of the lenses in posterior subcapsular congenital cataract patients and in normal children. There were 1533 differentially expressed genes from 19,072 genes in the lens epithelial cells of the posterior subcapsular congenital cataract patients compared to in the normal controls at a cut-off criteria of |log2 fold change| of >1 and a p-value of <0.05, including 847 downregulated genes and 686 upregulated genes. To further narrow down the DEGs, we utilised the stricter criteria of |log2 fold change| of >1 and an FDR value of <0.05, and we identified 551 DEGs, including 97 upregulated genes and 454 downregulated genes. This study also identified 1263 differentially expressed genes of the 18,755 genes in lens cortex and nuclear fibres, including 646 downregulated genes and 617 upregulated genes. The downregulated genes in epithelial cells were significantly enriched in the structural constituent of lenses, lens development and lens fibre cell differentiation. After filtering the DEGs using the databases iSyTE and Cat-Map, several high-priority candidate genes related to posterior subcapsular congenital cataract such as GRIFIN, HTRA1 and DAPL1 were identified. The findings of our study may provide a deeper understanding of the mechanisms of posterior subcapsular congenital cataract and help in the prevention and treatment of this disease.Entities:
Keywords: lens epithelial cells; lens fibre cells; posterior subcapsular congenital cataract; transcriptomics analysis
Mesh:
Substances:
Year: 2021 PMID: 34946854 PMCID: PMC8702110 DOI: 10.3390/genes12121904
Source DB: PubMed Journal: Genes (Basel) ISSN: 2073-4425 Impact factor: 4.096
Primers for the real-time quantitative PCR (RT-qPCR) assay.
| Target | F/R | Primer Sequence (5′→3′) | Amplicon Size (BP) |
|---|---|---|---|
| CRYGC | Forward | TCCCAACTACCAAGGTCAACA | 232 |
| Reverse | GTGGAGGGAACGGATCTCG | ||
| CRYGB | Forward | CACCTCACTGAAATTCACTCCC | 125 |
| Reverse | CCCCAATCAAGAAACCTCCTGT | ||
| CRYGA | Forward | GGTCCAATCCTGCCGTATAATTC | 109 |
| Reverse | ACAGGCGCAGTCATCAGTG | ||
| CRYBB1 | Forward | GTGCTCAAATCTGGCAGACC | 92 |
| Reverse | GGAAGTTGGACTGCTCAAAGG | ||
| CRYBA1 | Forward | GGGCAAGAGGATGGAGTTCAC | 122 |
| Reverse | CACAGAAGCTGGTATGCTCATAA | ||
| HBA2 | Forward | CAAGACCTACTTCCCGCACTTCG | 341 |
| Reverse | GGGCAGGAGGAACGGCTACC | ||
| HBA1 | Forward | TCAACTTCAAGCTCCTAAGCCACTG | 110 |
| Reverse | CACAGAAGCCAGGAACTTGTCCAG | ||
| HBB | Forward | AGGAGAAGTCTGCCGTTACTG | 190 |
| Reverse | CCGAGCACTTTCTTGCCATGA | ||
| S100A9 | Forward | CTGTGTGGCTCCTCGGCTTTG | 98 |
| Reverse | TGGTGGAAGGTGTTGATGATGGTC | ||
| HBG2 | Forward | GTGGAAGATGCTGGAGGAGAAACC | 106 |
| Reverse | TGATGGCAGAGGCAGAGGACAG | ||
| APOE | Forward | GTTGCTGGTCACATTCCTGG | 146 |
| Reverse | GCAGGTAATCCCAAAAGCGAC | ||
| TSPAN12 | Forward | CCAGAGAAGATTCCGTGAAGTG | 107 |
| Reverse | GTCCCTCATCCAAGCAGAAAC | ||
| PRSS35 | Forward | CATCGAATGCCAGAAAGAACTCC | 135 |
| Reverse | GTCGGCTCAAGAACCAAATCT | ||
| ASS1 | Forward | TCCGTGGTTCTGGCCTACA | 126 |
| Reverse | GGCTTCCTCGAAGTCTTCCTT | ||
| SULF1 | Forward | GATCCCCGAGGTTCAGAGGA | 178 |
| Reverse | GGTGTAGTCACAAAGGCATTGA | ||
| METRN | Forward | CACAGACACCGCCAGGCAAG | 103 |
| Reverse | CCACTCCTCTCCCGTCCACAC | ||
| PRAP1 | Forward | ACAGCCTGTACCACCCTCC | 82 |
| Reverse | AGCACCTGGTGATTTGGCATC | ||
| RAMP1 | Forward | CCAGGAGGCTAACTACGGTG | 297 |
| Reverse | GGGACCACGATGAAGGGGTA | ||
| TMEM54 | Forward | TGGGCCATGTGAGCTTCATC | 176 |
| Reverse | GAGGTAGCGTGACAACACGAT | ||
| GAPDH | Forward | GGAGCGAGATCCCTCCAAAAT | 197 |
| Reverse | GGCTGTTGTCATACTTCTCATGG |
RNA-seq samples, read metrics and mapped ratios.
| Sample | Tissue | Raw Reads | Clean Reads | Clean Read-Pairs | Average Length | Mapped |
|---|---|---|---|---|---|---|
| PSC patient 1 | Capsules | 79,150,688 | 23,475,256 | 11,737,628 | 138.3 | 88.80% |
| PSC patient 2 | Capsules | 92,790,046 | 36,750,674 | 18,375,337 | 141.9 | 93.40% |
| PSC patient 3 | Capsules | 102,532,016 | 47,760,460 | 23,880,230 | 142.0 | 91.70% |
| PSC patient 4 | Capsules | 100,012,388 | 32,018,416 | 16,009,208 | 142.4 | 92.60% |
| PSC patient 5 | Capsules | 98,193,322 | 36,350,310 | 18,175,155 | 134.7 | 79.10% |
| PSC patient 6 | Capsules | 100,226,088 | 40,541,834 | 20,270,917 | 134.1 | 79.90% |
| NC 1 | Capsules | 127,355,192 | 60,141,116 | 30,070,558 | 144.6 | 95.60% |
| NC 2 | Capsules | 100,869,818 | 37,378,548 | 18,689,274 | 138.0 | 86.40% |
| NC 3 | Capsules | 111,902,712 | 47,398,990 | 23,699,495 | 141.5 | 92.20% |
| NC 4 | Capsules | 127,358,610 | 48,182,942 | 24,091,471 | 144.2 | 94% |
| NC 5 | Capsules | 120,259,640 | 52,969,554 | 26,484,777 | 134.6 | 90.60% |
| NC 6 | Capsules | 91,405,500 | 31,710,346 | 15,855,173 | 133.6 | 84.20% |
| NC 7 | Capsules | 125,882,600 | 56,962,562 | 28,481,281 | 136.5 | 93% |
| NC 8 | Capsules | 131,778,762 | 54,214,656 | 27,107,328 | 135.5 | 91.70% |
| PSC patient 1 | Cortex | 123,977,234 | 45,747,380 | 22,873,690 | 141.6 | 93.40% |
| PSC patient 3 | Cortex | 91,869,478 | 25,684,820 | 12,842,410 | 137.9 | 85.90% |
| PSC patient 4 | Cortex | 110,104,320 | 109,339,070 | 54,669,535 | 150.0 | 97.60% |
| PSC patient 5 | Cortex | 128,652,528 | 48,532,586 | 24,266,293 | 138.7 | 89.40% |
| PSC patient 6 | Cortex | 116,294,432 | 47,393,278 | 23,696,639 | 136.5 | 84.80% |
| NC 1 | Cortex | 98,977,182 | 32,642,774 | 16,321,387 | 141.8 | 92.40% |
| NC 4 | Cortex | 167,149,114 | 67,734,538 | 33,867,269 | 142.4 | 95.10% |
| NC 5 | Cortex | 94,542,668 | 93,252,442 | 46,626,221 | 148.9 | 96.90% |
| NC 6 | Cortex | 114,900,736 | 113,734,102 | 56,867,051 | 148.8 | 97.90% |
| NC 7 | Cortex | 92,822,214 | 92,085,706 | 46,042,853 | 149.5 | 97.90% |
PSC, posterior subcapsular congenital cataract; NC, normal control.
Figure 1Differentially expressed genes (DEGs) in posterior subcapsular congenital cataract patients compared with in normal control samples. (a) Volcano plots of the DEGs in the anterior lens capsule samples. Blue dots indicate upregulated genes, and purple ones represent downregulated genes; (b) hierarchical clustering performed on the DEGs in the anterior lens capsule samples; highly expressed genes are shown in pink, and the lower ones are shown in blue; C indicates congenital cataract samples, while N represents normal control samples; (c) volcano plots of the DEGs in cortex and nuclear fibres; blue dots indicate upregulated genes, and purple dots represent downregulated genes; (d) hierarchical clustering performed on the DEGs in cortex and nuclear fibres.
The top 5 upregulated and downregulated DEGs in the anterior lens capsule samples of the posterior subcapsular congenital cataract patients.
| DEG | Symbol | Description | Log2 | False Discovery Rate (FDR) Value | |
|---|---|---|---|---|---|
| Downregulated | CRYGC | Crystallin gamma C | −8.117 | 3.04 × 10−15 | 6.00 × 10−12 |
| CRYGB | Crystallin gamma B | −7.952 | 4.24 × 10−14 | 6.30 × 10−11 | |
| CRYGA | Crystallin gamma A | −7.818 | 4.67 × 10−18 | 1.61 × 10−14 | |
| CRYBB1 | Crystallin beta B1 | −7.695 | 3.07 × 10−22 | 2.11 × 10−18 | |
| CRYBA1 | Crystallin beta A1 | −7.667 | 7.63 × 10−24 | 7.00 × 10−20 | |
| Upregulated | HBA2 | Hemoglobin subunit alpha 2 | 10.182 | 1.20 × 10−41 | 2.21 × 10−37 |
| HBA1 | Hemoglobin subunit alpha 1 | 9.838 | 1.27 × 10−44 | 3.48 × 10−40 | |
| HBB | Hemoglobin subunit beta | 9.414 | 4.16 × 10−49 | 2.29 × 10−44 | |
| S100A9 | S100 calcium binding protein A9 | 5.087 | 3.54 × 10−15 | 6.71 × 10−12 | |
| HBG2 | Hemoglobin subunit gamma 2 | 4.863 | 2.18 × 10−6 | 4.59 × 10−4 |
Figure 2Gene ontology (GO) annotation and Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrichment analysis results for the DEGs of the posterior subcapsular congenital cataract patients compared with those of the normal controls. (a) The top 30 GO enrichment of the DEGs in the anterior lens capsule samples; (b) the top 20 KEGG enrichment analysis results of the DEGs in the anterior lens capsule samples; (c) the top 30 GO enrichment of the DEGs in the cortex and nuclear fibres; (d) the top 20 KEGG enrichment analysis results of the DEGs in cortex and nuclear fibres.
Figure 3Validation of RNA-sequencing results by RT-qPCR. (a) RT-qPCR validation results of the five upregulated genes and the five downregulated genes identified by RNA-sequencing analysis in the anterior lens capsule samples; (b) RT-qPCR validation results of the five upregulated genes and the four downregulated genes identified by RNA-sequencing analysis in cortex and nuclear fibres.
The top 5 upregulated and top 4 downregulated DEGs in the lens fibre cells of the posterior subcapsular congenital cataract patients.
| DEGs | Symbol | Description | Log2 | FDR Value | |
|---|---|---|---|---|---|
| Downregulated | APOE | Apolipoprotein E | −5.889 | 1.47 × 10−11 | 9.71 × 10−8 |
| TSPAN12 | Tetraspanin 12 | −4.435 | 3.64 × 10−7 | 0.001 | |
| PRSS35 | Protease, serine 35 | −4.249 | 2.21 × 10−6 | 0.004 | |
| ASS1 | Argininosuccinate Synthase 1 | −3.786 | 6.89 × 10−7 | 0.002 | |
| SULF1 | Sulfatase 1 | −3.338 | 3.63 × 10−5 | 0.028 | |
| Upregulated | METRN | Meteorin, glial cell differentiation regulator | 2.872 | 5.07 × 10−6 | 0.007 |
| PRAP1 | Proline rich acidic Protein 1 | 2.852 | 2.85 × 10−5 | 0.024 | |
| RAMP1 | Receptor activity-modifying protein 1 | 2.311 | 1.56 × 10−5 | 0.016 | |
| TMEM54 | Transmembrane protein 54 | 1.921 | 1.37 × 10−6 | 0.003 |
Figure 4Images of immunohistochemistry of the stained HTRA1 for transparent lens from donors of different ages. (a). Image of a 19-day-old boy; (b) image of a 2-month-old boy; (c) image of a 3-month-old girl; (d) image of a 15-month-old boy; (e) image of a 19-year-old girl; (f) negative control image of a 2-month-old boy. The results indicated that the HTRA1 protein was located in the epithelial cells and outer fibre cells. The images are taken at a 20× magnification. Scale bar: 50 μm.